LXEO - Lexeo Therapeutics, Inc.
7.2
-0.240 -3.333%
Share volume: 1,431,602
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$7.44
-0.24
-0.03%
Summary score
33%
Profitability
35%
Dept financing
23%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-16.99%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
19.09%
Debt ratio change over timeo
0%
Current Ratio
6.8%
Quick Ratio
0%
Cash Position Ratio
4.83%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-20.2%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
22.13%
Debt ratio change over timeo
0%
Current Ratio
5.45%
Quick Ratio
0%
Cash Position Ratio
1.61%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-15.06%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
16%
Debt ratio change over time
0%
Current Ratio
7.4%
Quick Ratio
0%
Cash Position Ratio
2.37%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LXEO | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 28.34% | 5.51% | 6.15% |
| Return on assets | -16.99% | 3.06% | 3.18% | 2.21% |
| Return on sales | 0% | 28.09% | 27.06% | 23.01% |
| Return on invested capital | 0% | 6.42% | 3.22% | 6.7% |
| Profitability | 0% | 98% | 66% | 68% |
| Total debt ratio | 19.09% | 93.19% | 66.22% | 44.66% |
| Debt ratio change over time | 0% | 12.76% | 169.64% | 13.01% |
| Dept financing | 5% | 27% | 43% | 14% |
| Current Ratio | 5.45% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 1.61% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 30% | 25% | 37% |
| Short-term ratios | LXEO | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -20.2% | 3.09% | 4.74% | 1.98% |
| Return on sales | 0% | 23.81% | 35.93% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 33% | 50% | 26% |
| Total debt ratio | 22.13% | 91.88% | 65.29% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 25% | 18% | 11% |
| Current Ratio | 5.45% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 1.61% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 29% | 39% | 46% |